Publications by authors named "Roberto de Lisa"

Claim this Profile
P
Paediatric medicines development for Duchenne muscular dystrophy: An EU regulatory perspective.
Sylvie Benchetrit, Céline Chu, Dimitrios Athanasiou, Sabine Scherer, Fernando de Andres Trelles, Roberto De Lisa

J Neuromuscul Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development.
Roberto De Lisa, Fernando de Andres-Trelles, Ralph Bax, Sara Galluzzo, Brian Alward

Front Med (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation.
Dominik Karres, María José Pino-Barrio, Sylvie Benchetrit, Norbert Benda, Pierre Cochat, Roberto de Lisa

Br J Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries.
Mike Du, Francesco Dernie, Martí Català, Antonella Delmestri, Wai Yi Man, Roberto De Lisa

Eur J Intern Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Good Pharmacovigilance Practice in Paediatrics: An Overview of the Updated European Medicines Agency Guidelines.
Janet Sultana, Cosimo Zaccaria, Roberto de Lisa, Francesco Rossi, Annalisa Capuano

Paediatr Drugs· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee.
Peter Arlett, Geraldine Portier, Roberto de Lisa, Kevin Blake, Noel Wathion

Nat Rev Drug Discov· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A48G polymorphism in the D1 receptor genes associated with bipolar I disorder.
Giovanni Severino, Donatella Congiu, Claudia Serreli, Roberto De Lisa, Caterina Chillotti

Am J Med Genet B Neuropsychiatr Genet· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
Giovanni Severino, Caterina Chillotti, Roberto De Lisa, Maria Del Zompo, Raffaella Ardau

Ann Pharmacother· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis